Skip Navigation

Great Point Partners

Featured Company

This divestiture structured as a growth recapitalization helped launch Caprion as a leading, independent proteomic drug target discovery and biomarker services company.

More on Caprion
More on GPP’s Pharma & Biotech Infrastructure Investments
More Featured Companies
Great Point’s growth recapitalization has helped to establish Biotronic as one of the largest independent intra-operative neurophysiological monitoring providers in the country.

More on Biotronic
More Featured Companies
Great Point’s growth recapitalization has helped Connecture meet the increasing demand from states for the creation of health insurance exchanges.

More on Connecture
More Featured Companies
Great Point’s growth capital investment enabled Cytovance to meet growing client demand by funding facility, service and personnel expansion at its advanced research and manufacturing facilities.

More on Cytovance
More on GPP’s Pharma & Biotech Infrastructure Investments
More Featured Companies
Great Point's growth capital investment enabled Aris Teleradiology to accelerate their growth plans and meet growing client demand as a leading provider of professional outsourced radiology services.

More on Aris
More Featured Companies
Great Point's growth recapitalization has helped to establish ProPT as one of the largest physical therapy providers in the New York Metro area.

More on ProPT
More Featured Companies
This growth recapitalization has helped Equian become a leading business process outsourcer of complex medical claim repricing and bill review services to health care payors.

More on Equian
More Featured Companies
Great Point's growth recapitalization financed Citra's acquisition of MZI Healthcare and enabled Citra to become a single source vendor across payment and benefit administration, population health technology and service offerings for small to mid-size healthcare providers.

More on Citra
More Featured Companies
Great Point's growth recapitalization has helped Corrona accelerate the expansion of its patient registries into other autoimmune and chronic disease areas to better support comparative effectiveness research and post-marketing safety surveillance.

More on Corrona
More on GPP’s Pharma & Biotech Infrastructure Investments
More Featured Companies
Great Point's growth recapitalization enabled Softbox to accelerate its growth plans as a leading developer and manufacturer of temperature controlled packaging solutions to pharmaceutical and biotechnology companies.

More on Softbox
More on GPP’s Pharma & Biotech Infrastructure Investments
More Featured Companies
Equian video
Click here to listen to Russ Sherlock, Co-Founder and Chairman of Equian, speak about growing EBITDA 10-fold with GPP
Caprion Proteomics video
Click here to listen to Martin LeBlanc, CEO of Caprion Proteomics, speak about partnering with GPP
Cytovance Video
Click here to listen to Darren Head, CEO of Cytovance Biologics, speak about growing the value of his business 7.4-fold with GPP

News